DSM appoints new executive vp corporate strategy & acquisitions

Company: dsm-firmenich

Philip Eykerman, currently partner at McKinsey & Company’s Brussels office, is to join DSM as executive vp corporate strategy & acquisitions, reporting to Feike Sijbesma, ceo and chairman of the managing board of DSM.

Eykerman will succeed Hein Schreuder who will retire from the company on at the end of December after 20 years at DSM. DSM says Hein has played a key role in the transformation of the company as well as in the acquisitions and divestments of the company over the last 15 years.

With a track record of strategy development and M&A strategy and integration, DSM says Eykerman is well positioned to lead the company’s corporate strategy and acquisition department and drive the development of its strategic growth agenda.

You may also like

Ingredients
Can Pentavitin take hyaluronic acid’s crown as the beloved skin care hydrator?

Can Pentavitin take hyaluronic acid’s crown as the beloved skin care hydrator?

More beauty brands are infusing plant-derived moisturising ingredient, Pentavitin, into their formulations because it can bind moisture to the keratin in the skin for 72 hours without it evaporating, providing longer-term hydration. Beauty Writer Bethan King investigates
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients
FDA adds bemotrizinol to list of permitted sunscreen ingredients in the US, its first update in 20 years

FDA adds bemotrizinol to list of permitted sunscreen ingredients in the US, its first update in 20 years

Bemotrizinol, which is widely used in Europe, has been added to the FDA’s list of permitted sunscreen active ingredients. It is said to protect against both ultraviolet A and B rays and has low levels of absorption through the skin into the body
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients
8 trends from in-cosmetics Global 2026: from ‘blue longevity’ to precision peptides

8 trends from in-cosmetics Global 2026: from ‘blue longevity’ to precision peptides

Cosmetics Business walked the show floor to bring you our edit of the standout trends from this year’s beauty ingredient launches
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients
Beauty’s World War Z: ‘Zombie cells’ are the new longevity buzzword

Beauty’s World War Z: ‘Zombie cells’ are the new longevity buzzword

‘Zombie cells’ are the latest buzzword in longevity. Julia Wray explores why, when it comes to skin ageing, these undead troublemakers are less horror story and more opportunity
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients
The ingredients powering the next wave of sun care innovation

The ingredients powering the next wave of sun care innovation

Amid a demand for novel textures and a backdrop of complex regulatory requirements, the onus is on suppliers to create new ingredients that smooth the path for sun care formulation, writes Julia Wray
Ingredients
dsm-firmenich makes Middle East push with creative fragrance concept Po ONE Lab

dsm-firmenich makes Middle East push with creative fragrance concept Po ONE Lab

The Swiss fragrance and flavour company has partnered with luxury fragrance boutique Villa Po ONE on a new concept in Riyadh, Saudi Arabia
Ingredients
dsm-firmenich welcomes FDA proposal to expand US sunscreen actives, paving the way for PARSOL Shield

dsm-firmenich welcomes FDA proposal to expand US sunscreen actives, paving the way for PARSOL Shield

This proposal marks a historic milestone as it follows the first-ever Tier 1 OTC Monograph Order Request (OMOR) to be submitted to FDA – by dsm-firmenich - to amend OTC Monograph M020 and permit PARSOL® Shield at concentrations up to 6%
Subscribe now